Ceiling effect (pharmacology)

In pharmacology, the term ceiling effect refers to the property of increasing doses of a given medication to have progressively smaller incremental effect (an example of diminishing returns). Mixed agonist-antagonist opioids, such as nalbuphine, serve as a classic example of the ceiling effect; increasing the dose of a narcotic frequently leads to smaller and smaller gains in relief of pain. In many cases, the severity of side effects from a medication increases as the dose increases, long after its therapeutic ceiling has been reached.

The term is defined as "the phenomenon in which a drug reaches a maximum effect, so that increasing the drug dosage does not increase its effectiveness."^[1] Sometimes drugs cannot be compared across a wide range of treatment situations because one drug has a ceiling effect.^{[citation needed]}

Sometimes the desired effect increases with dose, but side-effects worsen or start being dangerous, and risk to benefit ratio increases. This is because of occupation of all the receptors in a given specimen.

See also

• Agonist–antagonist opioids
• Buprenorphine
• Codeine
• Dose–response relationship
• Pain ladder
• Weber–Fechner law

References

External links

• Is there a ceiling effect of transdermal buprenorphine? Preliminary data in cancer patients
• Clinical evidence for an LH ‘ceiling’ effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation
• Analgesic effect of i.v. paracetamol: possible ceiling effect of paracetamol in postoperative pain

This page was last edited on 7 February 2022, at 03:22